Literature DB >> 5675508

Susceptibility of coagulase-negative staphylococci to lysostaphin and other antibiotics.

W A Zygmunt, H P Browder, P A Tavormina.   

Abstract

In general, coagulase-negative staphylococci were found to be relatively less susceptible to the lytic action of lysostaphin than coagulase-positive staphylococci. To achieve, arbitrarily, a lysis greater than 75%, it was necessary to use an increased concentration of enzyme or a longer incubation period than that usually required with coagulase-positive strains. For the most part, the cultures studied were sensitive to oxacillin, cloxacillin, dicloxacillin, nafcillin, ancillin, cephalothin, cephaloridine, fusidic acid, lincomycin, novobiocin, and neomycin [median minimal inhibitory concentrations (MIC) of 1.56 mug/ml or less]. Some degree of resistance (median MIC values of 12.5 mug/ml or greater) to benzylpenicillin, ampicillin, methicillin, tetracycline, chloretetracycline, erythromycin, ristocetin, and lysostaphin was found. Ten methicillin-resistant, coagulase-negative staphylococal strains were found to be cross-resistant to all nine of the penicillins tested, but much less resistant to the two cephalosporin analogues. In several instances, some of these strains seemed to be more sensitive to benzylpenicillin and to certain of the semisynthetic penicillins than to methicillin. Of the 18 antibiotics tested with the viable plate count method, the methicillin-resistant strains were found to be the most sensitive to lincomycin and novobiocin.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5675508      PMCID: PMC547614          DOI: 10.1128/am.16.8.1168-1173.1968

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  10 in total

1.  IN VITRO ACTIVITY OF PENICILLINS AGAINST STAPHYLOCOCCUS ALBUS.

Authors:  J O KJELLANDER; J O KLEIN; M FINLAND
Journal:  Proc Soc Exp Biol Med       Date:  1963 Aug-Sep

2.  RESISTANCE TO METHICILLIN, ISOXAZOLYL PENICILLINS, AND CEPHALOTHIN IN STAPHYLOCOCCUS AUREUS.

Authors:  K R ERIKSEN; I ERICHSEN
Journal:  Acta Pathol Microbiol Scand       Date:  1964

3.  LYSOSTAPHIN: ENZYMATIC MODE OF ACTION.

Authors:  H P BROWDER; W A ZYGMUNT; J R YOUNG; P A TAVORMINA
Journal:  Biochem Biophys Res Commun       Date:  1965-04-23       Impact factor: 3.575

4.  Occurrence of serious bacterial infections since introduction of antibacterial agents.

Authors:  M FINLAND; W F JONES; M W BARNES
Journal:  J Am Med Assoc       Date:  1959-08-29

5.  Observations on Staphylococcus albus septicemia in mice and men.

Authors:  I M SMITH; P D BEALS; K R KINGSBURY; H F HASENCLEVER
Journal:  AMA Arch Intern Med       Date:  1958-09

6.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

7.  The problem of associating coagulase-negative staphylococci with disease.

Authors:  E L Quinn; F Cox; M Fisher
Journal:  Ann N Y Acad Sci       Date:  1965-07-23       Impact factor: 5.691

8.  Staphylococcic endocarditis.

Authors:  E L Quinn; F Cox; E H Drake
Journal:  JAMA       Date:  1966-06-06       Impact factor: 56.272

9.  STAPHYLOCOCCUS ALBUS IN WOUND INFECTION AND IN SEPTICEMIA.

Authors:  T S WILSON; R D STUART
Journal:  Can Med Assoc J       Date:  1965-07-03       Impact factor: 8.262

10.  RESISTANCE OF COAGULASE-POSITIVE STAPHYLOCOCCI TO METHICILLIN AND OXACILLIN.

Authors:  C F GRAVENKEMPER; J L BRODIE; W M KIRBY
Journal:  J Bacteriol       Date:  1965-04       Impact factor: 3.490

  10 in total
  22 in total

1.  epr, which encodes glycylglycine endopeptidase resistance, is homologous to femAB and affects serine content of peptidoglycan cross bridges in Staphylococcus capitis and Staphylococcus aureus.

Authors:  M Sugai; T Fujiwara; K Ohta; H Komatsuzawa; M Ohara; H Suginaka
Journal:  J Bacteriol       Date:  1997-07       Impact factor: 3.490

Review 2.  Use of enzyme tests in characterization and identification of aerobic and facultatively anaerobic gram-positive cocci.

Authors:  S Bascomb; M Manafi
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

Review 3.  Coagulase-negative staphylococci and the epidemiological typing of Staphylococcus epidermidis.

Authors:  J T Parisi
Journal:  Microbiol Rev       Date:  1985-06

4.  Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 HydH5 virion-associated peptidoglycan hydrolase: fusions, deletions, and synergy with LysH5.

Authors:  Lorena Rodríguez-Rubio; Beatriz Martínez; Ana Rodríguez; David M Donovan; Pilar García
Journal:  Appl Environ Microbiol       Date:  2012-01-20       Impact factor: 4.792

5.  Characterization of staphylococci from patients with toxic shock syndrome.

Authors:  B Aliu; M S Bergdoll
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

Review 6.  Peptidoglycan types of bacterial cell walls and their taxonomic implications.

Authors:  K H Schleifer; O Kandler
Journal:  Bacteriol Rev       Date:  1972-12

7.  Relative rates of lysis of staphylococcal cell walls by lytic enzymes from various bacteriophage types.

Authors:  E C Schuytema; H L Glenn; C C Doughty
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

8.  Lysostaphin Lysibody Leads to Effective Opsonization and Killing of Methicillin-Resistant Staphylococcus aureus in a Murine Model.

Authors:  Assaf Raz; Anna Serrano; Maneesha Thaker; Tricia Alston; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

9.  Staphylococcus epidermidis BV: antibiotic resistance patterns, physiological characteristics, and bacteriophage susceptibility.

Authors:  S Schaefler
Journal:  Appl Microbiol       Date:  1971-10

10.  Comparison of cephalothin and cefamandole prophylaxis during insertion of prosthetic heart valves.

Authors:  G L Archer; R E Polk; R J Duma; R Lower
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.